Metabolic Changes Associated With Weight Gain After Treatment of Achalasia
NCT07334639 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2026-01-13
Summary
This goal of the study is to assess the effect of weight gain in patients with achalasia after they are treated. The main question to be answered is if weight gain after achalasia treatment is associated with worsening metabolic status. Patients will be compared between their baseline status at the time of treatment and 1 year after treatment. Participants will have metabolic tests performed at these 2 times including blood tests.
Conditions
- Achalasia, Esophageal
Sponsors & Collaborators
-
Hadassah Medical Organization
collaborator OTHER -
Assaf-Harofeh Medical Center
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-01-15
- Primary Completion
- 2028-01-01
- Completion
- 2029-01-01
Countries
- Israel
Study Locations
More Related Trials
-
The Effect of 40gr Okara on Gastric Emptying
NCT01079585 ·Status: UNKNOWN ·Phase: NA
-
Effect of Nigella Sativa on Nonalcoholic Steatohepatitis and Steatosis
NCT02307344 ·Status: UNKNOWN ·Phase: NA
-
Mediterranean Diet Versus Paleolithic Diet for the Treatment of Non Alcohlic Fatty Liver Disease
NCT04400864 ·Status: UNKNOWN ·Phase: NA
-
Ghrelin in Cystic Fibrosis
NCT00763477 ·Status: UNKNOWN ·Phase: NA
-
Study of IW-1701, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Type I or II Achalasia
NCT02931565 ·Status: TERMINATED ·Phase: PHASE2
-
The Effects of Metreleptin in Congenital Leptin Deficiency
NCT04063488 ·Status: COMPLETED
-
Gastric Emptying and Gallbladder Motility Study
NCT00940849 ·Status: COMPLETED ·Phase: NA
-
Examination of the Lipid Metabolism of the Liver After Choline Substitution in Cystic Fibrosis
NCT03312140 ·Status: COMPLETED ·Phase: NA
-
Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver.
NCT06843148 ·Status: RECRUITING ·Phase: NA
-
Chia Supplementation and Non Alcoholic Fatty Liver Disease
NCT03942822 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of S-adenosyl-l-methionine in Treatment of Alcoholic Hepatitis With Cholestasis
NCT02024295 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Bile Acids on the Secretion of Satiation Peptides in Humans
NCT01674946 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of Foods on Bile Acids, Metabolites, and Inflammation
NCT05245357 ·Status: UNKNOWN ·Phase: NA
-
Regulation of FGF21 by Nutritional Challenges
NCT00968747 ·Status: COMPLETED ·Phase: NA
-
Repetitive Brake Activation
NCT02511366 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Phosphatidylcholine in NAFLD
NCT04411862 ·Status: COMPLETED ·Phase: PHASE3
-
N-Acetylcysteine in Biliary Atresia After Kasai Portoenterostomy
NCT03499249 ·Status: COMPLETED ·Phase: PHASE2
-
Regulation of Human Intestinal Bile Acid Transport in Health and Disease
NCT00018681 ·Status: COMPLETED
-
High Oral Loading Dose of Cholecalciferol in Non-Alcoholic Fatty Liver Disease
NCT05578404 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of FXR Activation on Hepatic Lipid and Glucose Metabolism
NCT00465751 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effect of Bile Acids on Satiety, Cell Function and Body Weight in Patients With Obesity and Abnormal Satiety Phenotype
NCT05314374 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study Evaluating Efficacy, Safety and Molecular Mechanism of N-acetylcysteine Supplementation in Patients With Hepatic and Post Hepatic Jaundice
NCT06236165 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Tolerability of Apevinat BC Compared to Vitamin Complex
NCT01295450 ·Status: UNKNOWN ·Phase: PHASE3
-
Biolizin for Improving Functional Poor Appetite in Children Aged 6 to 36 Months (CTBE2502)
NCT07153549 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Dark Chocolate in Achalasia Patients
NCT00790465 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2